NCT07562321 AI-SUPPORTED FLIPPED LEARNING IN BREAST SELF-EXAMINATION TRAINING
| NCT ID | NCT07562321 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baskent University |
| Condition | Artifical Intelligence |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-03-20 |
| Primary Completion | 2026-05-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-03-20 with a primary completion date of 2026-05-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The global increase in cancer cases has made breast cancer the second most common cancer after lung cancer and a primary health problem among women. Early diagnosis is the most critical factor in improving survival rates and quality of life in breast cancer. Breast self-examination (BSE), which enables individuals to notice changes in their own breast tissue during the early diagnosis process, is a low-cost and effective awareness method. It is essential that nurses, who play a key role in raising public awareness on this issue, and nursing students, who are the future healthcare professionals, have sufficient knowledge and practical skills in BSE. However, the literature shows that even if students have theoretical knowledge, their application rates are low. In this context, the "AI-Supported Flipped Learning" model, which goes beyond traditional methods and supports active learning, personalized feedback, and digital literacy, has the potential to be an innovative solution in nursing education. Objective: This study aims to evaluate the effect of AI-supported flipped learning model and traditional education on the knowledge levels and performance skills of nursing students regarding BSE knowledge and skills.
Eligibility Criteria
Inclusion Criteria: * Being a second-year student in a nursing undergraduate program * Not having previously received breast examination training * Having signed the voluntary consent form Exclusion Criteria: * Having any health problem that would prevent continuing to work * Requesting to withdraw from work voluntarily
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07562321 clinical trial?
This trial is open to participants of all sexes, studying Artifical Intelligence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07562321 currently recruiting?
Yes, NCT07562321 is actively recruiting participants. Contact the research team at betulsahin@baskent.edu.tr for enrollment information.
Where is the NCT07562321 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07562321 clinical trial?
NCT07562321 is sponsored by Baskent University. The trial plans to enroll 80 participants.